The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice J. VetulaniF. PavoneI. Nalepa Pages: 1205 - 1213
Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system T. M. GajjarL. I. AndersonD. E. Dluzen Pages: 1215 - 1224
Selegiline reduces N-methyl-D-aspartic acid induced perturbation of neurotransmission but it leaves NMDA receptor dependent long-term potentiation intact in the hippocampus M. NiittykoskiA. HaapalinnaJ. Sirviö Pages: 1225 - 1240
A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition A. ClarkeF. BrewerT. H. Corn Pages: 1241 - 1255
A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition A. ClarkeE. S. JohnsonD. G. MacMahon Pages: 1257 - 1271
Selegiline’s neuroprotective capacity revisited P. RiedererL. Lachenmayer Commentary Pages: 1273 - 1278
Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain M. J. HurleyD. C. MashP. Jenner Pages: 1279 - 1288
Activation of basal ganglia loops in idiopathic Parkinson’s disease: a PET study A. ThielR. HilkerW.-D. Heiss Pages: 1289 - 1301
Spatial correlations between the vacuolation, prion protein deposition and surviving neurons in variant Creutzfeldt-Jakob Disease (vCJD) R. A. ArmstrongP. L. LantosN. J. Cairns 19 November 2003 Pages: 1303 - 1311
The neuroprotective effects of Cerebrolysin™ in a transgenic model of Alzheimer’s disease are associated with improved behavioral performance E. RockensteinA. AdameE. Masliah Pages: 1313 - 1327
Mutation analysis of the zinc transporter gene SLC30A4 reveals no association with periodic catatonia on chromosome 15q15 S. KüryC. RubieG. Stöber Short Communication Pages: 1329 - 1332